“Chinese entrants such as Intco Medical and Blue Sail Medical are looking to build new markets and distribution channels. We expect them to underprice their products even at modest margins to achieve scale and new customers,” says Chew to The Edge Singapore.
With the global vaccine roll-out underway and Chinese glove manufacturers joining the fray, could oversupply be on the horizon for the glove industry?
According to Paul Chew, head of research at Phillip Securities, Chinese upstarts may use lower prices to gain a foothold in an industry currently dominated by Thai and Malaysian companies.
